Kirkwood JM - Search Results

1

Co-expression of TNF receptors 1 and 2 on melanomas facilitates soluble TNF-induced resistance to MAPK pathway inhibitors.

Sander CA, Rush EA, Shi J, Arantes LMRB, Tesi RJ, Ross MA, Calderon MJ, Watkins SC, Kirkwood JM, Ferris RL, Butterfield LH, Vujanovic L. Sander CA, et al. Among authors: kirkwood jm. J Transl Med. 2022 Jul 25;20(1):331. doi: 10.1186/s12967-022-03538-w. J Transl Med. 2022. PMID: 35879777 Free PMC article.

2

Recent advances in the care of the patient with malignant melanoma.

Reintgen D, Balch CM, Kirkwood J, Ross M. Reintgen D, et al. Ann Surg. 1997 Jan;225(1):1-14. doi: 10.1097/00000658-199701000-00001. Ann Surg. 1997. PMID: 8998115 Free PMC article. Review.

3

Tumor necrosis factor-alpha-promoted expression of Bcl-2 and inhibition of mitochondrial cytochrome c release mediate resistance of mature dendritic cells to melanoma-induced apoptosis.

Esche C, Shurin GV, Kirkwood JM, Wang GQ, Rabinowich H, Pirtskhalaishvili G, Shurin MR. Esche C, et al. Among authors: kirkwood jm. Clin Cancer Res. 2001 Mar;7(3 Suppl):974s-979s. Clin Cancer Res. 2001. PMID: 11300499

4

IL-18-induced CD83+CCR7+ NK helper cells.

Mailliard RB, Alber SM, Shen H, Watkins SC, Kirkwood JM, Herberman RB, Kalinski P. Mailliard RB, et al. Among authors: kirkwood jm. J Exp Med. 2005 Oct 3;202(7):941-53. doi: 10.1084/jem.20050128. J Exp Med. 2005. PMID: 16203865 Free PMC article.

5

IL-12p70 and IL-18 gene-modified dendritic cells loaded with tumor antigen-derived peptides or recombinant protein effectively stimulate specific Type-1 CD4+ T-cell responses from normal donors and melanoma patients in vitro.

Vujanovic L, Ranieri E, Gambotto A, Olson WC, Kirkwood JM, Storkus WJ. Vujanovic L, et al. Among authors: kirkwood jm. Cancer Gene Ther. 2006 Aug;13(8):798-805. doi: 10.1038/sj.cgt.7700964. Epub 2006 Apr 28. Cancer Gene Ther. 2006. PMID: 16645618

6

Mitotic arrest, apoptosis, and sensitization to chemotherapy of melanomas by methionine deprivation stress.

Kokkinakis DM, Brickner AG, Kirkwood JM, Liu X, Goldwasser JE, Kastrama A, Sander C, Bocangel D, Chada S. Kokkinakis DM, et al. Among authors: kirkwood jm. Mol Cancer Res. 2006 Aug;4(8):575-89. doi: 10.1158/1541-7786.MCR-05-0240. Mol Cancer Res. 2006. PMID: 16908595

7

A mycoplasma peptide elicits heteroclitic CD4+ T cell responses against tumor antigen MAGE-A6.

Vujanovic L, Mandic M, Olson WC, Kirkwood JM, Storkus WJ. Vujanovic L, et al. Among authors: kirkwood jm. Clin Cancer Res. 2007 Nov 15;13(22 Pt 1):6796-806. doi: 10.1158/1078-0432.CCR-07-1909. Clin Cancer Res. 2007. PMID: 18006782

8

Next generation of immunotherapy for melanoma.

Kirkwood JM, Tarhini AA, Panelli MC, Moschos SJ, Zarour HM, Butterfield LH, Gogas HJ. Kirkwood JM, et al. J Clin Oncol. 2008 Jul 10;26(20):3445-55. doi: 10.1200/JCO.2007.14.6423. J Clin Oncol. 2008. PMID: 18612161 Review.

9

Immunization with analog peptide in combination with CpG and montanide expands tumor antigen-specific CD8+ T cells in melanoma patients.

Fourcade J, Kudela P, Andrade Filho PA, Janjic B, Land SR, Sander C, Krieg A, Donnenberg A, Shen H, Kirkwood JM, Zarour HM. Fourcade J, et al. Among authors: kirkwood jm. J Immunother. 2008 Oct;31(8):781-91. doi: 10.1097/CJI.0b013e318183af0b. J Immunother. 2008. PMID: 18779741 Free PMC article. Clinical Trial.

10

Prognostic significance of serum S100B protein in high-risk surgically resected melanoma patients participating in Intergroup Trial ECOG 1694.

Tarhini AA, Stuckert J, Lee S, Sander C, Kirkwood JM. Tarhini AA, et al. Among authors: kirkwood jm. J Clin Oncol. 2009 Jan 1;27(1):38-44. doi: 10.1200/JCO.2008.17.1777. Epub 2008 Dec 1. J Clin Oncol. 2009. PMID: 19047287 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

600 results

Search Page